Drug Index



Mechanism :

Clofazimine exerts a slow bactericidal effect on Mycobacterium leprae (Hansen's bacillus). It inhibits mycobacterial growth and binds preferentially to mycobacterial DNA. It also exerts anti-inflammatory properties in controlling erythema nodosum leprosum reactions. However, its precise mechanisms of action are unknown.

Indication :

• Lepromatous leprosy

• Multidrug resistant tuberculosis

Contraindications :

There are no known contraindications.

Dosing :

2-4 mg/kg/day PO OD.

Adverse Effect :

Pigmentation from pink to brownish-black, ichthyosis, dryness, rash, pruritus, diarrhea, nausea, vomiting, gastrointestinal intolerance, conjunctival and corneal pigmentation due to clofazimine crystal deposits, discoloration of urine, faeces, sputum, sweat, elevated blood sugar; elevated ESR.

Interaction :

Dapsone: May inhibit the anti-inflammatory activity of clofazimine have not been confirmed. If leprosy-associated inflammatory reactions develop in patients being treated with dapsone and clofazimine, it is still advisable to continue treatment with both drugs.

03/05/2020 22:11:11 Clofazimine
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0